AI assistant
Sending…
Marvel Biosciences Corp. — AGM Information 2023
Oct 26, 2023
47732_rns_2023-10-26_441fcaa3-c681-40cc-bc30-05266097185a.pdf
AGM Information
Open in viewerOpens in your device viewer
October 26, 2023
==> picture [203 x 45] intentionally omitted <==
Filed via SEDAR
To All Applicable Exchanges and Securities Administrators
Subject: Marvel Biosciences Corp. (the "Issuer") Notice of Meeting and Record Date
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
| MeetingType: | Annual General Special Meeting |
|---|---|
| MeetingDate: | January9,2023 |
| Record Date for Notice of Meeting: | November 20,2023 |
| Record Date for Voting (if applicable): | November 20,2023 |
| Beneficial OwnershipDetermination Date: | November 20,2023 |
| Class of Securities Entitled to Vote: | Common class |
| ISIN: | CA57384M1077 |
| Issuer sending proxymaterials directlyto NOBOs: | No |
| Issuerpayingfor deliveryto OBOs: | No |
| Notice and Access for Beneficial Holders: | No |
| Notice and Access for Registered Holders: | No |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company as agent for Marvel Biosciences Corp.
More from Marvel Biosciences Corp.
Remuneration Information
2026
May 20
Capital/Financing Update
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Investor Presentation
2026
Apr 23
Regulatory Filings
2026
Apr 23
Capital/Financing Update
2026
Apr 17
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 13